Levin Capital Strategies, L.P. Aura Biosciences, Inc. Transaction History
Levin Capital Strategies, L.P.
- $990 Million
- Q2 2025
A detailed history of Levin Capital Strategies, L.P. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 1,495,560 shares of AURA stock, worth $9.8 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
1,495,560
Previous 1,360,768
9.91%
Holding current value
$9.8 Million
Previous $7.97 Million
17.41%
% of portfolio
0.95%
Previous 0.88%
Shares
10 transactions
Others Institutions Holding AURA
# of Institutions
96Shares Held
40.3MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$45.3 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$32 Million0.06% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$21.7 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$19.9 Million5.39% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$19.7 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $192M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...